Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AGENUS INC
Report date June 16, 2020 · Filed June 18, 2020
Section 16 reporting ended · disclosed 2020-06-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,972,968 |
Ending reported balance
After 2020-06-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-06-16 · Sale · Disposed 72,080 · Balance 17,114,888 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.700, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Row 2 · 2020-06-17 · Sale · Disposed 141,920 · Balance 16,972,968 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.550 to $3.710, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.700, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.550 to $3.710, inclusive.
Merus N.V.
Report date January 25, 2021 · Filed January 25, 2021
Section 16 reporting ended · disclosed 2021-01-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,550,000 |
Reported balance
After 2021-01-25 transaction · row 1
1 source rowRow 1 · 2021-01-25 · Grant · Acquired 350,000 · Balance 3,550,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2021 Filed Jan 25, 2021 21:48 UTC | Merus N.V. MRUS · Entity 70740 | GrantCommon Stock | 350,000 | $24.75 | $8,662,500.00 |
DisclosureSEC source: 0001104659-21-007219 · tm214038-1_4seq1.xml · nonDerivative · entry 1 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550,000 Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:30 UTC | AGENUS INC AGEN · Entity 5774 | SaleCommon Stock | 141,920 | $3.66 | $518,831.14 |
DisclosureSEC source: 0001104659-20-074735 · a4.xml · nonDerivative · entry 2 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,972,968 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.550 to $3.710, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:30 UTC | AGENUS INC AGEN · Entity 5774 | SaleCommon Stock | 72,080 | $3.66 | $264,007.42 |
DisclosureSEC source: 0001104659-20-074735 · a4.xml · nonDerivative · entry 1 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,114,888 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.700, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 00:47 UTC | AGENUS INC AGEN · Entity 5774 | SaleCommon Stock | 384,025 | $3.57 | $1,372,159.73 |
DisclosureSEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 3 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,186,968 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.635, inclusive. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 00:47 UTC | AGENUS INC AGEN · Entity 5774 | SaleCommon Stock | 9,100 | $3.58 | $32,556.16 |
DisclosureSEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 2 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,570,993 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.650, inclusive. Read SEC document |
| June 11, 2020 Filed Jun 16, 2020 00:47 UTC | AGENUS INC AGEN · Entity 5774 | SaleCommon Stock | 183,875 | $3.77 | $692,785.84 |
DisclosureSEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 1 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,580,093 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.920, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| February 14, 2017 Filed Feb 14, 2017 22:26 UTC | AGENUS INC AGEN · Entity 5774 | PurchaseCommon Stock | 10,000,000 | $6.00 | $60,000,000.00 |
DisclosureSEC source: 0001104659-17-009341 · a4.xml · nonDerivative · entry 1 INCYTE CORP · CIK 0000879169 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,763,968 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.